5-amino-1mq 5mg injection dosage Peptide Dosing Guide: Oral Protocol, Reconstitution & Safety (2026) 5-Amino-1MQ 5mg | Janoshik COA

C-terminal fragment of human growth hormone (amino acids 176-191) ~12.5 more potent lipolysis than full-length hGH in adipose assays Does not compete for GH receptor or affect IGF-1 levels Beta-3 adrenergic receptor and hormone-sensitive lipase activation Distinct from AOD-9604 (unmodified natural fragment) Research reference HGH Fragment 176-191 Dosage Published Research Protocols The following reference points are drawn from published research literature

Restoring function in exhausted CD8 T cells during chronic viral infection

During this consultation, we check your vitals and review your health history to tailor the treatment to your specific needs

If morning training isn't possible, split the AOD-9604 dose: half in the morning, half 45 minutes before your scheduled session to capture both circadian peak and exercise-induced oxidation

The peptide does not bind to growth hormone receptors in muscle tissue, does not stimulate protein synthesis or muscle hypertrophy, shows no effects on bone metabolism or growth, demonstrates no organ enlargement or proliferative effects, and avoids the connective tissue changes associated with growth hormone